ClinicalTrials.govpublic full text
Trial of M4344 and Niraparib in Patients With Poly (ADP-ribose) Polymerase (PARP) Resistant Recurrent Ovarian Cancer
ovarian cancer recurrent, ovarian cancer, parp resistant, atr inhibitor, m4344, niraparib, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 891484
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.